Predictive Oncology Statistics Share Statistics Predictive Oncology has 10.22M
shares outstanding. The number of shares has increased by 33.96%
in one year.
Shares Outstanding 10.22M Shares Change (YoY) 33.96% Shares Change (QoQ) 23.88% Owned by Institutions (%) 2.58% Shares Floating 10.07M Failed to Deliver (FTD) Shares 5,922 FTD / Avg. Volume 3.15%
Short Selling Information The latest short interest is 110.68K, so 1.15% of the outstanding
shares have been sold short.
Short Interest 110.68K Short % of Shares Out 1.15% Short % of Float 1.17% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.37 and the forward
PE ratio is 9.5.
Predictive Oncology's PEG ratio is
0.01.
PE Ratio -0.37 Forward PE 9.5 PS Ratio 2.75 Forward PS 0.5 PB Ratio -22.07 P/FCF Ratio -0.41 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Predictive Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.62,
with a Debt / Equity ratio of -10.52.
Current Ratio 0.62 Quick Ratio 0.51 Debt / Equity -10.52 Debt / EBITDA -0.21 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $70.6K Profits Per Employee $-530.49K Employee Count 23 Asset Turnover 0.33 Inventory Turnover 2.14
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -25.43% in the
last 52 weeks. The beta is 1.19, so Predictive Oncology's
price volatility has been higher than the market average.
Beta 1.19 52-Week Price Change -25.43% 50-Day Moving Average 0.85 200-Day Moving Average 1.02 Relative Strength Index (RSI) 39.89 Average Volume (20 Days) 188,001
Income Statement In the last 12 months, Predictive Oncology had revenue of 1.62M
and earned -12.2M
in profits. Earnings per share was -2.32.
Revenue 1.62M Gross Profit 797.68K Operating Income -10.94M Net Income -12.2M EBITDA -10.16M EBIT -10.94M Earnings Per Share (EPS) -2.32
Full Income Statement Balance Sheet The company has 734.67K in cash and 2.13M in
debt, giving a net cash position of -1.4M.
Cash & Cash Equivalents 734.67K Total Debt 2.13M Net Cash -1.4M Retained Earnings -180.43M Total Assets 5.87M Working Capital -1.12M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.97M
and capital expenditures -9.51K, giving a free cash flow of -10.98M.
Operating Cash Flow -10.97M Capital Expenditures -9.51K Free Cash Flow -10.98M FCF Per Share -2.01
Full Cash Flow Statement Margins Gross margin is 49.12%, with operating and profit margins of -673.69% and -751.39%.
Gross Margin 49.12% Operating Margin -673.69% Pretax Margin -668.81% Profit Margin -751.39% EBITDA Margin -625.97% EBIT Margin -673.69% FCF Margin -676.44%
Dividends & Yields POAI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for POAI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 24, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Apr 24, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -48.43 Piotroski F-Score 2
